{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T22:25:06Z","timestamp":1783549506874,"version":"3.55.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","ejinme.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.ejim.2024.01.004","type":"journal-article","created":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T06:48:39Z","timestamp":1705819719000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["The impact of colchicine on patients with acute and chronic coronary artery disease"],"prefix":"10.1016","volume":"125","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6366-6211","authenticated-orcid":false,"given":"Mehdi","family":"Madanchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mabelle","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregorio","family":"Tersalvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Maria Cioffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Attinger-Toller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florim","family":"Cuculi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reto","family":"Kurmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Bossard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ejim.2024.01.004_bib0001","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1161\/01.CIR.91.11.2844","article-title":"Molecular bases of the acute coronary syndromes","volume":"91","author":"Libby","year":"1995","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.ejim.2024.01.004_bib0002","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ejim.2024.01.004_bib0003","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1007\/s00296-011-1900-4","article-title":"Subclinical atherosclerosis in gouty arthritis patients: a comparative study","volume":"32","author":"\u00c7ukurova","year":"2012","journal-title":"Rheumatol Int"},{"issue":"10","key":"10.1016\/j.ejim.2024.01.004_bib0004","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1002\/art.21288","article-title":"Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors","volume":"52","author":"Chung","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.ejim.2024.01.004_bib0005","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/joim.12406","article-title":"Inflammation and plaque vulnerability","volume":"278","author":"Hansson","year":"2015","journal-title":"J Intern Med"},{"issue":"12","key":"10.1016\/j.ejim.2024.01.004_bib0006","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.ejim.2024.01.004_bib0007","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMoa1809798","article-title":"Low-dose methotrexate for the prevention of atherosclerotic events","volume":"380","author":"Ridker","year":"2019","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.ejim.2024.01.004_bib0008","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/jama.2014.11061","article-title":"Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial","volume":"312","author":"O'Donoghue","year":"2014","journal-title":"JAMA"},{"issue":"18","key":"10.1016\/j.ejim.2024.01.004_bib0009","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1056\/NEJMoa1315878","article-title":"Darapladib for preventing ischemic events in stable coronary heart disease","volume":"370","author":"White","year":"2014","journal-title":"N Engl J Med"},{"issue":"37","key":"10.1016\/j.ejim.2024.01.004_bib0010","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.2174\/138161211798764771","article-title":"Anti-inflammatory treatment of acute coronary syndromes","volume":"17","author":"Della Bona","year":"2011","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.ejim.2024.01.004_bib0011","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.atherosclerosis.2018.07.014","article-title":"Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions","volume":"276","author":"Raggi","year":"2018","journal-title":"Atherosclerosis"},{"issue":"30","key":"10.1016\/j.ejim.2024.01.004_bib0012","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1093\/eurheartj\/ehw171","article-title":"Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial","volume":"37","author":"Kleveland","year":"2016","journal-title":"Eur Heart J"},{"issue":"10118","key":"10.1016\/j.ejim.2024.01.004_bib0013","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(17)32814-3","article-title":"Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial","volume":"391","author":"Ridker","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2024.01.004_bib0014","doi-asserted-by":"crossref","DOI":"10.1136\/heartjnl-2020-317108","article-title":"Colchicine for acute and chronic coronary syndromes","author":"Imazio","year":"2020","journal-title":"Heart"},{"issue":"11","key":"10.1016\/j.ejim.2024.01.004_bib0015","doi-asserted-by":"crossref","first-page":"687","DOI":"10.5694\/mja14.00846","article-title":"Colchicine\u2014a short history of an ancient drug","volume":"201","author":"Nerlekar","year":"2014","journal-title":"Med J Aust"},{"issue":"42","key":"10.1016\/j.ejim.2024.01.004_bib0016","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1093\/eurheartj\/ehv318","volume":"36","author":"Adler","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2024.01.004_bib0017","article-title":"Safety and efficacy of colchicine in patients with coronary artery disease: a systematic review and meta-analysis","author":"Ullah","year":"2020","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.ejim.2024.01.004_bib0018","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.amjcard.2020.10.043","article-title":"Meta-analysis evaluating the utility of colchicine in secondary prevention of coronary artery disease","volume":"140","author":"Xia","year":"2021","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejim.2024.01.004_bib0019","doi-asserted-by":"crossref","DOI":"10.1007\/s11739-020-02606-7","article-title":"Efficacy and safety of colchicine for secondary prevention of coronary heart disease: a systematic review and meta-analysis","author":"Xiang","year":"2021","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.ejim.2024.01.004_bib0020","article-title":"Drug repurposing? Cardiovascular effect of colchicine on patients with coronary artery disease: a systematic review and meta-analysis","author":"Tien","year":"2020","journal-title":"J Cardiol"},{"key":"10.1016\/j.ejim.2024.01.004_bib0021","article-title":"Colchicine for secondary prevention of cardiovascular disease: a systematic review and meta-analysis of randomized controlled trials","author":"Samuel","year":"2020","journal-title":"Can J Cardiol"},{"issue":"4","key":"10.1016\/j.ejim.2024.01.004_bib0022","doi-asserted-by":"crossref","first-page":"e13464","DOI":"10.1111\/eci.13464","article-title":"Effect of low-dose colchicine in acute and chronic coronary syndromes: a systematic review and meta-analysis","volume":"51","author":"Aimo","year":"2021","journal-title":"Eur J Clin Invest"},{"issue":"26","key":"10.1016\/j.ejim.2024.01.004_bib0023","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.ejim.2024.01.004_bib0024","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1182\/blood.V83.9.2451.2451","article-title":"P-glycoprotein expression and function in circulating blood cells from normal volunteers","volume":"83","author":"Klimecki","year":"1994","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ejim.2024.01.004_bib0025","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s11926-008-0036-3","article-title":"Colchicine: its mechanism of action and efficacy in crystal-induced inflammation","volume":"10","author":"Nuki","year":"2008","journal-title":"Curr Rheumatol Rep"},{"issue":"10","key":"10.1016\/j.ejim.2024.01.004_bib0026","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.clinthera.2014.07.017","article-title":"Mechanism of action of colchicine in the treatment of gout","volume":"36","author":"Dalbeth","year":"2014","journal-title":"Clin Ther"},{"issue":"3","key":"10.1016\/j.ejim.2024.01.004_bib0027","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1084\/jem.171.3.715","article-title":"Downregulation of tumor necrosis factor receptors on macrophages and endothelial cells by microtubule depolymerizing agents","volume":"171","author":"Ding","year":"1990","journal-title":"J Exp Med"},{"issue":"4\u20135","key":"10.1016\/j.ejim.2024.01.004_bib0028","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0171-2985(96)80027-1","article-title":"Inhibition of LPS-induced tumor necrosis factor-alpha production by colchicine and other microtubule disrupting drugs","volume":"195","author":"Li","year":"1996","journal-title":"Immunobiology"},{"issue":"4","key":"10.1016\/j.ejim.2024.01.004_bib0029","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1172\/JCI116759","article-title":"Crystal-induced neutrophil activation. IV. Specific inhibition of tyrosine phosphorylation by colchicine","volume":"92","author":"Roberge","year":"1993","journal-title":"J Clin Invest"},{"issue":"7081","key":"10.1016\/j.ejim.2024.01.004_bib0030","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.ejim.2024.01.004_bib0031","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/ni.3457","article-title":"Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS","volume":"17","author":"Park","year":"2016","journal-title":"Nat Immunol"},{"issue":"10","key":"10.1016\/j.ejim.2024.01.004_bib0032","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1016\/j.clinthera.2019.07.015","article-title":"Colchicine as a novel therapy for suppressing chemokine production in patients with an acute coronary syndrome: a pilot study","volume":"41","author":"Tucker","year":"2019","journal-title":"Clin Ther"},{"issue":"10","key":"10.1016\/j.ejim.2024.01.004_bib0033","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/0248-8663(96)80790-9","article-title":"Colchicine: recent data on pharmacokinetics and clinical pharmacology","volume":"16","author":"Chappey","year":"1995","journal-title":"Rev Med Interne"},{"issue":"suppl_1","key":"10.1016\/j.ejim.2024.01.004_bib0034","doi-asserted-by":"crossref","first-page":"i4","DOI":"10.1093\/rheumatology\/kex453","article-title":"Update on colchicine, 2017","volume":"57","author":"Slobodnick","year":"2018","journal-title":"Rheumatology (Oxford, England)"},{"issue":"5","key":"10.1016\/j.ejim.2024.01.004_bib0035","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.amjmed.2014.12.010","article-title":"Colchicine: old and new","volume":"128","author":"Slobodnick","year":"2015","journal-title":"Am J Med"},{"issue":"8","key":"10.1016\/j.ejim.2024.01.004_bib0036","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1002\/art.30389","article-title":"Novel evidence-based colchicine dose-reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4\/P-glycoprotein inhibitors","volume":"63","author":"Terkeltaub","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.ejim.2024.01.004_bib0037","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/BOR.0000000000000031","article-title":"Safety profile of anti-gout agents: an update","volume":"26","author":"Stamp","year":"2014","journal-title":"Curr Opin Rheumatol"},{"issue":"10","key":"10.1016\/j.ejim.2024.01.004_bib0038","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/acr.21773","article-title":"2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"10.1016\/j.ejim.2024.01.004_bib0039","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/art.27327","article-title":"High versus low dosing of oral colchicine for early acute gout flare: twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study","volume":"62","author":"Terkeltaub","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"16","key":"10.1016\/j.ejim.2024.01.004_bib0040","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021198","article-title":"Colchicine in patients with coronary artery disease: a systematic review and meta-analysis of randomized trials","volume":"10","author":"Kofler","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"23 Suppl 1","key":"10.1016\/j.ejim.2024.01.004_bib0041","first-page":"Iii27","article-title":"Role of endothelial dysfunction in atherosclerosis","volume":"109","author":"Davignon","year":"2004","journal-title":"Circulation"},{"issue":"3\u20134","key":"10.1016\/j.ejim.2024.01.004_bib0042","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00424-017-1941-y","article-title":"Macrophages in vascular inflammation and atherosclerosis","volume":"469","author":"Cochain","year":"2017","journal-title":"Pflugers Arch"},{"issue":"13","key":"10.1016\/j.ejim.2024.01.004_bib0043","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1161\/CIRCULATIONAHA.105.542738","article-title":"Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial","volume":"112","author":"Imazio","year":"2005","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.ejim.2024.01.004_bib0044","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1056\/NEJMoa1208536","article-title":"A randomized trial of colchicine for acute pericarditis","volume":"369","author":"Imazio","year":"2013","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.ejim.2024.01.004_bib0045","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1093\/eurheartj\/ehq319","article-title":"COlchicine for the prevention of the post-pericardiotomy syndrome (COPPS): a multicentre, randomized, double-blind, placebo-controlled trial","volume":"31","author":"Imazio","year":"2010","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.ejim.2024.01.004_bib0046","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/jama.2014.11026","article-title":"Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation: the COPPS-2 randomized clinical trial","volume":"312","author":"Imazio","year":"2014","journal-title":"JAMA"},{"issue":"23","key":"10.1016\/j.ejim.2024.01.004_bib0047","first-page":"e199","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ejim.2024.01.004_bib0048","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ejim.2024.01.004_bib0049","first-page":"9","article-title":"Prevalence of ischemic heart disease in patients with familial Mediterranean fever","volume":"3","author":"Langevitz","year":"2001","journal-title":"Isr Med Assoc J"},{"issue":"4","key":"10.1016\/j.ejim.2024.01.004_bib0050","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jacc.2012.10.027","article-title":"Low-dose colchicine for secondary prevention of cardiovascular disease","volume":"61","author":"Nidorf","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"10.1016\/j.ejim.2024.01.004_bib0051","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med"},{"issue":"42","key":"10.1016\/j.ejim.2024.01.004_bib0052","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1093\/eurheartj\/ehaa659","article-title":"Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the colchicine cardiovascular outcomes trial (COLCOT)","volume":"41","author":"Bouabdallaoui","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2024.01.004_bib0053","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.120.050771","article-title":"Colchicine in patients with acute coronary syndrome: the Australian COPS randomized clinical trial","author":"Tong","year":"2020","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.ejim.2024.01.004_bib0054","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1161\/CIRCULATIONAHA.121.054610","article-title":"Colchicine in patients with acute coronary syndrome: two-year follow-up of the Australian COPS randomized clinical trial","volume":"144","author":"Tong","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2024.01.004_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2022.12.026","article-title":"Drivers of mortality in patients with chronic coronary disease in the low-dose colchicine 2 trial","volume":"372","author":"Opstal","year":"2023","journal-title":"Int J Cardiol"},{"issue":"5","key":"10.1016\/j.ejim.2024.01.004_bib0056","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104756","article-title":"Role of colchicine in stroke prevention: an updated meta-analysis","volume":"29","author":"Masson","year":"2020","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"2","key":"10.1016\/j.ejim.2024.01.004_bib0057","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/2396987320972566","article-title":"Colchicine for prevention of vascular inflammation in non-CardioEmbolic stroke (CONVINCE)\u2014study protocol for a randomised controlled trial","volume":"6","author":"Kelly","year":"2021","journal-title":"Eur Stroke J"},{"issue":"28","key":"10.1016\/j.ejim.2024.01.004_bib0058","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1093\/eurheartj\/ehab115","article-title":"Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials","volume":"42","author":"Fiolet","year":"2021","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.ejim.2024.01.004_bib0059","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jjcc.2020.11.010","article-title":"Drug repurposing? Cardiovascular effect of colchicine on patients with coronary artery disease: a systematic review and meta-analysis","volume":"77","author":"Tien","year":"2021","journal-title":"J Cardiol"},{"issue":"5","key":"10.1016\/j.ejim.2024.01.004_bib0060","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.cjca.2020.10.006","article-title":"Colchicine for secondary prevention of cardiovascular disease: a systematic review and meta-analysis of randomized controlled trials","volume":"37","author":"Samuel","year":"2021","journal-title":"Can J Cardiol"},{"issue":"1","key":"10.1016\/j.ejim.2024.01.004_bib0061","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13075-020-2120-7","article-title":"Adverse events during oral colchicine use: a systematic review and meta-analysis of randomised controlled trials","volume":"22","author":"Stewart","year":"2020","journal-title":"Arthritis Res Ther"},{"issue":"17","key":"10.1016\/j.ejim.2024.01.004_bib0062","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1093\/eurjpc\/zwab045","article-title":"Efficacy and safety of colchicine for the prevention of major cardiovascular and cerebrovascular events in patients with coronary artery disease: a systematic review and meta-analysis on 12,869 patients","volume":"28","author":"Andreis","year":"2022","journal-title":"Eur J Prev Cardiol"},{"issue":"1","key":"10.1016\/j.ejim.2024.01.004_bib0063","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.amjmed.2021.07.025","article-title":"Consensus statement regarding the efficacy and safety of long-term low-dose colchicine in gout and cardiovascular disease","volume":"135","author":"Robinson","year":"2022","journal-title":"Am J Med"},{"issue":"28","key":"10.1016\/j.ejim.2024.01.004_bib0064","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1093\/eurheartj\/ehab221","article-title":"Colchicine and the heart","volume":"42","author":"Imazio","year":"2021","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ejim.2024.01.004_bib0065","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/CIRCULATIONAHA.122.062714","article-title":"Survival after invasive or conservative management of stable coronary disease","volume":"147","author":"Hochman","year":"2023","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ejim.2024.01.004_bib0066","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s10620-019-05729-w","article-title":"Acute colchicine poisoning causes endotoxemia via the destruction of intestinal barrier function: the curative effect of endotoxin prevention in a murine model","volume":"65","author":"Horioka","year":"2020","journal-title":"Dig Dis Sci"},{"issue":"11","key":"10.1016\/j.ejim.2024.01.004_bib0067","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s40261-022-01209-8","article-title":"The effect of years-long exposure to low-dose colchicine on renal and liver function and blood creatine kinase levels: safety insights from the low-dose colchicine 2 (LoDoCo2) Trial","volume":"42","author":"van Broekhoven","year":"2022","journal-title":"Clin Drug Investig"},{"issue":"34","key":"10.1016\/j.ejim.2024.01.004_bib0068","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1093\/eurheartj\/ehac015","article-title":"Prevalence of statin intolerance: a meta-analysis","volume":"43","author":"Byty\u00e7i","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2024.01.004_bib0069","unstructured":"Jolly S.S. ClinicalTrials.gov [Internet]. A 2\u00a0\u00d7\u00a02 Factorial Randomized Controlled Trial of Colchicine and Spironolactone in Patients With Myocardial Infarction \/SYNERGY Stent Registry - Organization to Assess Strategies for Ischemic Syndromes 9; Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03048825."},{"issue":"7","key":"10.1016\/j.ejim.2024.01.004_bib0070","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/0735-1097(92)90624-V","article-title":"Ineffectiveness of colchicine for the prevention of restenosis after coronary angioplasty","volume":"19","author":"O'Keefe","year":"1992","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ejim.2024.01.004_bib0071","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s11239-011-0637-y","article-title":"Effect of colchicine compared with placebo on high sensitivity C-reactive protein in patients with acute coronary syndrome or acute stroke: a pilot randomized controlled trial","volume":"33","author":"Raju","year":"2012","journal-title":"J Thromb Thrombolysis"},{"issue":"16","key":"10.1016\/j.ejim.2024.01.004_bib0072","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.jacc.2013.01.055","article-title":"Colchicine treatment for the prevention of bare-metal stent restenosis in diabetic patients","volume":"61","author":"Deftereos","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.ejim.2024.01.004_bib0073","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.amjcard.2015.02.036","article-title":"Usefulness of colchicine to reduce perioperative myocardial damage in patients who underwent on-pump coronary artery bypass grafting","volume":"115","author":"Giannopoulos","year":"2015","journal-title":"Am J Cardiol"},{"issue":"15","key":"10.1016\/j.ejim.2024.01.004_bib0074","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1161\/CIRCULATIONAHA.115.017611","article-title":"Anti-inflammatory treatment with colchicine in acute myocardial infarction: a pilot study","volume":"132","author":"Deftereos","year":"2015","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ejim.2024.01.004_bib0075","first-page":"4","article-title":"Colchicine to reduce atrial fibrillation in the postoperative period of myocardial revascularization","volume":"107","author":"Zarpelon","year":"2016","journal-title":"Arq Bras Cardiol"},{"issue":"6\u20137","key":"10.1016\/j.ejim.2024.01.004_bib0076","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.acvd.2016.10.004","article-title":"COLIN trial: value of colchicine in the treatment of patients with acute myocardial infarction and inflammatory response","volume":"110","author":"Akodad","year":"2017","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.ejim.2024.01.004_bib0077","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ahj.2019.06.003","article-title":"The low dose colchicine after myocardial infarction (LoDoCo-MI) study: a pilot randomized placebo controlled trial of colchicine following acute myocardial infarction","volume":"215","author":"Hennessy","year":"2019","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.ejim.2024.01.004_bib0078","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.008717","article-title":"Effects of acute colchicine administration prior to percutaneous coronary intervention: COLCHICINE-PCI randomized trial","volume":"13","author":"Shah","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.ejim.2024.01.004_bib0079","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","author":"Nidorf","year":"2020","journal-title":"N Engl J Med"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620524000116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620524000116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T01:40:22Z","timestamp":1719798022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620524000116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":79,"alternative-id":["S0953620524000116"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2024.01.004","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of colchicine on patients with acute and chronic coronary artery disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2024.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}